162 related articles for article (PubMed ID: 2720662)
21. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
[TBL] [Abstract][Full Text] [Related]
22. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
[TBL] [Abstract][Full Text] [Related]
23. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.
Howell SB; Taetle R
Cancer Treat Rep; 1980; 64(4-5):611-6. PubMed ID: 7191778
[TBL] [Abstract][Full Text] [Related]
24. Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
Levine BS; Henry MC; Port CD; Richter WR; Urbanek MA
J Natl Cancer Inst; 1981 Jul; 67(1):201-6. PubMed ID: 6942191
[TBL] [Abstract][Full Text] [Related]
25. Cis DDP in combination with selenium and sulfur. Subcellular effect in kidney cells. Electron microprobe study.
Berry JP; Lespinats G
J Submicrosc Cytol Pathol; 1988 Jan; 20(1):59-65. PubMed ID: 3370622
[TBL] [Abstract][Full Text] [Related]
26. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
[TBL] [Abstract][Full Text] [Related]
27. Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats.
Francescato HD; Costa RS; Rodrigues Camargo SM; Zanetti MA; Lavrador MA; Bianchi MD
Pharmacol Res; 2001 Jan; 43(1):77-82. PubMed ID: 11207069
[TBL] [Abstract][Full Text] [Related]
28. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
Lee CK; Son SH; Park KK; Park JH; Lim SS; Kim SH; Chung WY
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
[TBL] [Abstract][Full Text] [Related]
29. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
[TBL] [Abstract][Full Text] [Related]
30. Interaction of vitamin C and selenium supplementation in the modification of mammary carcinogenesis in rats.
Ip C
J Natl Cancer Inst; 1986 Jul; 77(1):299-303. PubMed ID: 3088312
[TBL] [Abstract][Full Text] [Related]
31. [Two-route chemotherapy using the anticancer drug cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate].
Kuroiwa T; Baba T
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1011-7. PubMed ID: 3566300
[TBL] [Abstract][Full Text] [Related]
32. Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat.
Thompson HJ; Meeker LD; Kokoska S
Cancer Res; 1984 Jul; 44(7):2803-6. PubMed ID: 6722810
[TBL] [Abstract][Full Text] [Related]
33. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.
Nakashima-Kamimura N; Mori T; Ohsawa I; Asoh S; Ohta S
Cancer Chemother Pharmacol; 2009 Sep; 64(4):753-61. PubMed ID: 19148645
[TBL] [Abstract][Full Text] [Related]
34. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
[TBL] [Abstract][Full Text] [Related]
35. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
37. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
38. [Modification of the toxic effects of cis-dichlorodiammineplatinum].
Kulik GI; Chekhun VF; Pel'kis FP; Korol' VI; Boĭm TM
Eksp Onkol; 1985; 7(6):55-8. PubMed ID: 4085400
[TBL] [Abstract][Full Text] [Related]
39. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
Iwakawa M; Tofilon PJ; Arundel C; Milas L
Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of selenium intake enhances manifestation of renal toxicity of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
Toxicol Lett; 1987 Sep; 38(1-2):155-60. PubMed ID: 3629626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
